Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19

SARS-CoV-2 vaccinations have greatly reduced COVID-19 cases, but we must continue to develop our understanding of the nature of the disease and its effects on human immunity. Previously, we suggested that a dysregulated STAT3 pathway following SARS-Co-2 infection ultimately leads to PAI-1 activation...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuyama, Toshifumi, Yoshinaga, Steven K., Shibue, Kimitaka, Mak, Tak W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522258/
https://www.ncbi.nlm.nih.gov/pubmed/34663907
http://dx.doi.org/10.1038/s41418-021-00892-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522258/
https://www.ncbi.nlm.nih.gov/pubmed/34663907
http://dx.doi.org/10.1038/s41418-021-00892-y

Ejemplares similares